BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9669290)

  • 1. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
    Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
    Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
    Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
    Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
    Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
    Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management and follow-up of medullary thyroid carcinoma.
    Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
    J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
    Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
    Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
    Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
    Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of surgery for thyroid medullary cancer.
    Pelizzo MR; Bernante P; Piotto A; Toniato A; Girelli ME; Busnardo B; Rupolo M; Fassina A; Pennelli N
    Tumori; 1994 Dec; 80(6):427-32. PubMed ID: 7900231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma in Hong Kong Chinese patients.
    Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
    Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
    Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
    Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.